Phio Pharmaceuticals Corp. Quarterly Return On Equity in % from Q4 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Phio Pharmaceuticals Corp. quarterly/annual Return On Equity history and growth rate from Q4 2012 to Q3 2024.
  • Phio Pharmaceuticals Corp. Return On Equity for the quarter ending September 30, 2024 was -135 %, a 1.73% decline year-over-year.
  • Phio Pharmaceuticals Corp. annual Return On Equity for 2023 was -135 %, a 78.4% decline from 2022.
  • Phio Pharmaceuticals Corp. annual Return On Equity for 2022 was -75.5 %, a 52.6% decline from 2021.
  • Phio Pharmaceuticals Corp. annual Return On Equity for 2021 was -49.5 %, a 18.2% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -135 -2.29 -1.73% Jul 1, 2024 Sep 30, 2024
Q2 2024 -143 -22.8 -19% Apr 1, 2024 Jun 30, 2024
Q1 2024 -123 -21 -20.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -135 -59.2 -78.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -132 -64.4 -94.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -120 -60.7 -103% Apr 1, 2023 Jun 30, 2023
Q1 2023 -102 -49.8 -94.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -75.5 -26 -52.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -67.9 -17.9 -35.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -59.1 -10.2 -20.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -52.5 -1.69 -3.33% Jan 1, 2022 Mar 31, 2022
Q4 2021 -49.5 +11 +18.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -49.9 +20.7 +29.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -49 +32.5 +39.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -50.8 +53.6 +51.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -60.5 +42.2 +41.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -70.6 +4.33 +5.78% Jul 1, 2020 Sep 30, 2020
Q2 2020 -81.5 -1.13 -1.41% Apr 1, 2020 Jun 30, 2020
Q1 2020 -104 -8.63 -9.02% Jan 1, 2020 Mar 31, 2020
Q4 2019 -103 +51 +33.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 -75 +337 +81.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -80.4 +298 +78.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 -95.7 +218 +69.5% Jan 1, 2019 Mar 31, 2019
Q4 2018 -154 +103 +40% Oct 1, 2018 Dec 31, 2018
Q3 2018 -411 -232 -129% Jul 1, 2018 Sep 30, 2018
Q2 2018 -379 -200 -112% Apr 1, 2018 Jun 30, 2018
Q1 2018 -314 -133 -74% Jan 1, 2018 Mar 31, 2018
Q4 2017 -256 -117 -83.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 -180 -24.2 -15.5% Jul 1, 2017 Sep 30, 2017
Q2 2017 -178 -58.4 -48.7% Apr 1, 2017 Jun 30, 2017
Q1 2017 -180 -85.3 -89.7% Jan 1, 2017 Mar 31, 2017
Q4 2016 -139 -24.5 -21.3% Oct 1, 2016 Dec 31, 2016
Q3 2016 -156 -20.8 -15.5% Jul 1, 2016 Sep 30, 2016
Q2 2016 -120 +46.4 +27.9% Apr 1, 2016 Jun 30, 2016
Q1 2016 -95.1 +133 +58.4% Jan 1, 2016 Mar 31, 2016
Q4 2015 -115 +58.9 +33.9% Oct 1, 2015 Dec 31, 2015
Q3 2015 -135 +25.8 +16.1% Jul 1, 2015 Sep 30, 2015
Q2 2015 -166 -23.4 -16.3% Apr 1, 2015 Jun 30, 2015
Q1 2015 -229 -87.1 -61.6% Jan 1, 2015 Mar 31, 2015
Q4 2014 -174 +138 +44.3% Oct 1, 2014 Dec 31, 2014
Q3 2014 -160 +341 +68% Jul 1, 2014 Sep 30, 2014
Q2 2014 -143 +1.53K +91.4% Apr 1, 2014 Jun 30, 2014
Q1 2014 -141 -2.27K -107% Jan 1, 2014 Mar 31, 2014
Q4 2013 -312 -663 -189% Oct 1, 2013 Dec 31, 2013
Q3 2013 -502 Jul 1, 2013 Sep 30, 2013
Q2 2013 -1.67K Apr 1, 2013 Jun 30, 2013
Q1 2013 2.12K Jan 1, 2013 Mar 31, 2013
Q4 2012 351 Oct 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.